findmyKOL

Joseph Mikhael, MD

Enriched profile

Professor, Applied Cancer Research and Drug Discovery Division, Translational Genomics Research Institute · Translational Genomics Research Institute (TGen)

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Scottsdale, AZ · West · United StatesSpecialtyHematologyFocusMultiple Myeloma Research and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Joseph Mikhael is Professor, Applied Cancer Research and Drug Discovery Division, Translational Genomics Research Institute at Translational Genomics Research Institute (TGen). OpenAlex indexes 388 publications with 15,199 citations (h-index 64); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 21 Oct 2026

Overview

Updated 21 Oct 2026

Joseph Mikhael, M.D., is Professor, Applied Cancer Research and Drug Discovery Division, Translational Genomics Research Institute. The public record shows 388 publications with 15,199 citations (h-index 64), centered on Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Bone health and treatments. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 25 companies.

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Multiple Myeloma Research and Treatments
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 21 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Multiple Myeloma4 trialsLeukemia (AML/ALL/CML/CLL)Lymphoma

Research focus

OpenAlex concept fingerprint
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchBone health and treatmentsLymphoma Diagnosis and TreatmentAmyloidosis: Diagnosis, Treatment, Outcomes

Drugs & molecules

across trials, industry payments and publications
Sarclisageneric · IsatuximabClinical trials—Industry payments51Publications5Kyprolisgeneric · CarfilzomibClinical trials—Industry payments17Publications6Pomalystgeneric · PomalidomideClinical trials—Industry payments1Publications7Venclextageneric · VenetoclaxClinical trials—Industry payments7Publications1Mozobilgeneric · PlerixaforClinical trials1Industry payments6Publications—Revlimidgeneric · LenalidomideClinical trials—Industry payments4Publications2Xpoviogeneric · SelinexorClinical trials—Industry payments52Publications—Darzalexgeneric · DaratumumabClinical trials—Industry payments27Publications—Elrexfiogeneric · ElranatamabClinical trials—Industry payments27Publications—Blenrepgeneric · Belantamab mafodotinClinical trials—Industry payments12Publications—Abecmageneric · Idecabtagene vicleucelClinical trials—Industry payments10Publications—Imbruvicageneric · IbrutinibClinical trials—Industry payments7Publications—

Works with

trial sponsors and companies reporting payments
Karyopharm Therapeutics Inc.Clinical trials—Industry payments49Genzyme CorporationClinical trials—Industry payments43Pfizer Inc.Clinical trials—Industry payments34Janssen Biotech, Inc.Clinical trials—Industry payments26Celgene CorporationClinical trials—Industry payments23Sanofi-Aventis U.S. LLCClinical trials—Industry payments23Amgen Inc.Clinical trials—Industry payments18E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments16GlaxoSmithKline, LLC.Clinical trials—Industry payments13Abbvie Inc.Clinical trials—Industry payments8The Binding Site Inc.Clinical trials—Industry payments8Pharmacyclics LLC, An AbbVie CompanyClinical trials—Industry payments6Dr.Reddy's Laboratories,Inc.Clinical trials—Industry payments4Hexal AGClinical trials—Industry payments4Janssen Global Services, LLCClinical trials—Industry payments4Stemline Therapeutics Inc.Clinical trials—Industry payments4Janssen Research & Development, LLCClinical trials—Industry payments3Mayo ClinicClinical trials3Industry payments—Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments3AstraZeneca UK LimitedClinical trials—Industry payments2Genentech USA, Inc.Clinical trials—Industry payments1Pharming Healthcare, Inc.Clinical trials—Industry payments1PrECOG, LLC.Clinical trials1Industry payments—Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments1Sebia IncClinical trials—Industry payments1Tg Therapeutics, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
388publications

Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.

15,199citations

Total citations across indexed works.

64h-index

Hirsch index (OpenAlex). i10-index 165.

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 21 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 21 Oct 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 56 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 21 Oct 2026

35 congress contributions (2007–2025) across AACR, ASCO, ASH per OpenAlex. The most recent:

All 35 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 21 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 21 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
    Article720 citations2011
    doi.org ↗
  2. 02
    Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
    Article624 citations2009
    doi.org ↗
  3. 03
    Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
    Article545 citations2017
    doi.org ↗
  4. 04
    Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
    Article525 citations2017
    doi.org ↗
  5. 05
    Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
    Article500 citations2013
    doi.org ↗
All 388 cited works: search, sort and filter.Explore →

Network

Updated 21 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Shaji Kunnathu Kumar93Peter Leif Bergsagel79Craig B. Reeder75S. Vincent Rajkumar69Rafaël Fonseca68Martha Q. Lacy65A. Keith Stewart64Angela A. Dispenzieri63Francis K. Buadi56Philippe Moreau56Morie Abraham Gertz55David Dingli50Vivek Roy50Suzanne R. Hayman50Donna Ellen Reece47Suzanne Trudel42Meletios Athanasios Dimopoulos40Stephen J. Russell39John Anthony Lust38Thierry T.F. Facon35Robert A. Kyle34Kristina M. Laumann33Kwee Yong32Sandrine Macé31Christine I. Chen31Steven R. Zeldenrust30Vishal Kukreti30Marie‐Laure Risse29Roman Hájek29Prashant Kapoor26Philip R. Greipp26Paul Gerard Guy Richardson25Thomas Elmer Witzig24Saad Z. Usmani24Betsy R LaPlant23Sagar Lonial22Ivan Špıčka22Keith Stewart21Kenneth Carl Anderson21Marcelo Capra21

Online presence

Updated 21 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    myeloma.org/people/joseph-mikhael-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 21 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Medical Advisor

    International Myeloma Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
  • Treasurer

    American Society of Hematology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hematology.org ↗
  • Editorial Board Member

    Journal of Clinical Oncology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
  • Chair

    Diversity, Equity and Inclusion Council, Translational Genomics Research Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗
  • Active Member

    International Myeloma Working Group

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Consultant Hematologist and Director of Myeloma Research

    HonorHealth Research Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tgen.org ↗
  • Affiliate

    City of Hope Cancer Center, Phoenix, AZ

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.